Evidence map›Paper›PMID 34071405›Full record

ArticleInternational journal of molecular sciences2021

Multitargeted Approach for the Optimization of Morphogenesis and Barrier Formation in Human Skin Equivalents.

Arnout Mieremet, Richard W J Helder, Andreea Nadaban, Walter A Boiten, Gert S Gooris, Abdoelwaheb El Ghalbzouri, Joke A Bouwstra

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. The Fate of Epidermal Tight Junctions in theInternational journal of molecular sciences · 2022
    Article
  4. Synopsis of Barrier Function of Skin and Oral Mucosa-Volume 1.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Arnout MieremetDepartment of Dermatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Richard W J HelderDivision of BioTherapeutics, Leiden Academic Centre of Drug Research, Leiden University, 2333 CD Leiden, The Netherlands.
Andreea NadabanDivision of BioTherapeutics, Leiden Academic Centre of Drug Research, Leiden University, 2333 CD Leiden, The Netherlands.ORCID 0000-0002-4981-6268
Walter A BoitenDivision of BioTherapeutics, Leiden Academic Centre of Drug Research, Leiden University, 2333 CD Leiden, The Netherlands.
Gert S GoorisDivision of BioTherapeutics, Leiden Academic Centre of Drug Research, Leiden University, 2333 CD Leiden, The Netherlands.
Abdoelwaheb El GhalbzouriDepartment of Dermatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Joke A BouwstraDivision of BioTherapeutics, Leiden Academic Centre of Drug Research, Leiden University, 2333 CD Leiden, The Netherlands.
Leiden University · NLLeiden University Medical Center · NL

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek 13151
6 · The paper itself

Abstract

In vitro skin tissue engineering is challenging due to the manifold differences between the in vivo and in vitro conditions. Yet, three-dimensional (3D) human skin equivalents (HSEs) are able to mimic native human skin in many fundamental aspects. However, the epidermal lipid barrier formation, which is essential for the functionality of the skin barrier, remains compromised. Recently, HSEs with an improved lipid barrier formation were generated by (i) incorporating chitosan in the dermal collagen matrix, (ii) reducing the external oxygen level to 3%, and (iii) inhibiting the liver X receptor (LXR). In this study, we aimed to determine the synergic effects in full-thickness models (FTMs) with combinations of these factors as single-, double-, and triple-targeted optimization approaches. The collagen-chitosan FTM supplemented with the LXR inhibitor showed improved epidermal morphogenesis, an enhanced lipid composition, and a better lipid organization. Importantly, barrier functionality was improved in the corresponding approach. In conclusion, our leading optimization approach substantially improved the epidermal morphogenesis, barrier formation, and functionality in the FTM, which therefore better resembled native human skin.

Indexed as

MorphogenesisCells, CulturedChitosanChromatography, LiquidCollagenEpidermal CellsEpidermisHumansKeratinocytesLipid MetabolismLipidsLiver X ReceptorsMass SpectrometryScattering, Small AngleSkinSpectroscopy, Fourier Transform InfraredChitosanCollagenLipidsLiver X Receptorsceramideschitosanfree fatty acidshuman skin equivalentshypoxiamonounsaturatednuclear receptors/LXRskin

Identifiers

PMID34071405
PMCPMC8198964
OpenAlexW3165765395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.